AUGUST 2018
Measured by Google Analytics
FEATURED COMPANIES
Y-mAbs Therapeutics Looks at an $80 Million IPO
Alex Keown
22 Sep 2018
BIOSPACE
1
NHS wins landmark ruling against pharma companies over AMD drug
Allie Nawrat
22 Sep 2018
PHARMACEUTICAL TECH
2
FDA berates Chinese drugmaker tied to global valsartan recall
Eric Palmer
22 Sep 2018
FIERCE PHARMA
3
Why Former Novartis CEO Joe Jimenez Joined A Microbiome Startup`s Board
Matthew Herper
22 Sep 2018
4
Novartis drums up EU launch plans as CHMP gives thumbs up to Luxturna
Amber Tong
22 Sep 2018
5
EMA Extends Valsartan Review to Include Four More Active Substances
Ana Mulero
22 Sep 2018
RAPS
6
Going Its Own Way, European Regulators Reject Sarepta`s Exondys 51 for DMD
Mark Terry
22 Sep 2018
7
A $100 Million Biotech Deal has 2 Exec`s Kids` Deadly Diseases
Matthew Herper
22 Sep 2018
9
Immuno-Oncology Players Gritstone And Sutro Join The Biotech IPO Frenzy
Arlene Weintrau...
22 Sep 2018
10
MARKET PLACE
Amisulpride API (7kg) needed in Egypt
24 Sep 2018
Bipyridine Lactate needed in Egypt
24 Sep 2018
Sodium Palmitate API needed in Iran
24 Sep 2018
EP grade Spiramycin Impurities needed in Spain
22 Sep 2018
Bepotastine (1.5%) eye drop needed in India
20 Sep 2018
BLOG & ANALYSIS
This week, Phispers brings you the latest on the valsartan contamination. FDA and EMA have found the...
In August, the biotech boom of 2018 continued unabated and the Wall Street Journal reported that in...
This week, Phispers has news on Indian generic drug makers. First, Sun Pharma and Dr. Reddy’s ...
